scholarly journals Extracorporeal Membrane Oxygenation (ECMO) for Long-Term Support: Recent Advances

2019 ◽  
Author(s):  
R. Gregory Conway ◽  
Douglas Tran ◽  
Bartley P. Griffith ◽  
Zhongjun J. Wu
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Membrane Oxygenation ◽  
Recent Advances

Long‐term renal function after venoarterial extracorporeal membrane oxygenation

2021 ◽  
Vol 36 (3) ◽  
pp. 815-820
Author(s):  
Brian Ayers ◽  
Milica Bjelic ◽  
Neil Kumar ◽  
Katherine Wood ◽  
Bryan Barrus ◽  
...  
Keyword(s):  
Renal Function ◽  
Extracorporeal Membrane Oxygenation ◽  
Membrane Oxygenation ◽  
Venoarterial Extracorporeal Membrane Oxygenation

Long-term outcomes of adults with acute respiratory failure treated with veno-venous extracorporeal membrane oxygenation

2021 ◽  
pp. 0310057X2110423
Author(s):  
Emma L Gray ◽  
Paul Forrest ◽  
Timothy J Southwood ◽  
Richard J Totaro ◽  
Brian T Plunkett ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Respiratory Failure ◽  
Standard Deviation ◽  
Extracorporeal Membrane Oxygenation ◽  
Acute Respiratory Failure ◽  
Body Mass ◽  
Multiple Logistic Regression Analysis ◽  
Membrane Oxygenation ◽  
Retrospective Audit

Veno-venous extracorporeal membrane oxygenation is increasingly used for severe but potentially reversible acute respiratory failure in adults; however, there are limited data regarding long-term morbidity. At our institution, most patients requiring veno-venous extracorporeal membrane oxygenation have been followed up by a single physician. Our primary aim was to describe the serial long-term morbidity for respiratory, musculoskeletal and psychological functioning. A retrospective audit of inpatient and outpatient medical records was conducted. A total of 125 patients treated with veno-venous extracorporeal membrane oxygenation for primary respiratory failure were included. The patients were young (mean (standard deviation) age 43.7 (4.1) years), obese (mean (standard deviation) body mass index 30.8 (10.4) kg/m2), and mostly were male (59%). Most patients (60%) had no comorbidities. The survival rate to discharge was 70%, with body mass index and the number of comorbidities being independent predictors of survival on multiple logistic regression analysis. Over half (57%) of the Australian survivors had regular outpatient follow-up. They had a median of three reviews (range 1–9) over a median of 11.8 months (range 1.5-79) months. Breathlessness and weakness resolved in most within six months, with lung function abnormalities taking longer to resolve. Over half (60%) returned to employment within six months of discharge. Over a quarter (29%) displayed symptoms of anxiety, depression or post-traumatic stress disorder.

Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: Long‐term outcomes

2019 ◽  
Vol 33 (3) ◽  
pp. e13480 ◽  
Author(s):  
Jocelyn Bellier ◽  
Pierre Lhommet ◽  
Pierre Bonnette ◽  
Philippe Puyo ◽  
Morgan Le Guen ◽  
...  
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplantation ◽  
Primary Graft Dysfunction ◽  
Graft Dysfunction ◽  
Long Term Outcomes ◽  
Membrane Oxygenation ◽  
Grade 3

Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation

2015 ◽  
Vol 30 (5) ◽  
pp. 949-956 ◽  
Author(s):  
Aidan J.C. Burrell ◽  
Vincent A. Pellegrino ◽  
Rory Wolfe ◽  
Wen Kai Wong ◽  
David Jamie Cooper ◽  
...  
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Cardiogenic Shock ◽  
Term Survival ◽  
Long Term Survival ◽  
Membrane Oxygenation ◽  
Venoarterial Extracorporeal Membrane Oxygenation
Sign in / Sign up

Export Citation Format

Share Document